Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10296 |
| Vaccine Name | rHEV |
| Disease Name | Hepatitis E |
| Disease Classification | Hepatitic |
| Virus Name | Hepatitis E virus |
| Nucleic Acid Content | double stranded DNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Phase 2 |
| Manufacturer | GlaxoSmithKline |
| Year of Manufacturing | 2011 |
| Manufacturing Country | USA |
| Age | 18 - 58 years |
| Dosage | 3 doses at regimen of 0, 1, and 6 months |
| Administration Route | NA |
| Adjuvant | Aluminum (alum) |
| Target Strain | Capsid Protein ORF2 |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | National Institute of Health, Novavax |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.who.int/immunization/sage/meetings/2014/october/4_Hepatitis_E_vaccine_pipeline_final_29_Sept_14.pdf |
| Additional Links | NA |